Timothy Rolph sold $256K of Akero Therapeutics (AKRO)

Executed Apr 24 2025, disclosed Apr 28 2025, 4 days later.

Value, as filed

$256K

6,250 sh × $41.03

Executed

Apr 24 2025

the trade date, as filed

Disclosed

Apr 28 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TR Timothy Rolph Chief Scientific Officer profile →

Timothy Rolph (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AKRO. The largest single filing was $527K of AKRO (11,463 sh × $46.01, as filed), executed Oct 7 2025.

The name

AKRO AKRO AKRO · 63 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Timothy Rolph in AKRO

AKROSALE Akero Therapeutics, Inc. $527K
11,463 sh × $46.01
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $551K
12,466 sh × $44.17
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $616K
12,500 sh across 2 lots
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $542K
10,634 sh × $50.93
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $127K
2,358 sh × $54.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $2.0M
37,500 sh across 3 lots
Exec Jun 5 2025
Filed Jun 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $529K
12,200 sh across 2 lots
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. $135K
3,750 sh × $36.05
Exec Apr 7 2025
Filed Apr 10 2025 · 5:30 PM ET †